Analyst Price Target is $33.50
▲ +69.19% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Covetrus in the last 3 months. The average price target is $33.50, with a high forecast of $38.00 and a low forecast of $29.00. The average price target represents a 69.19% upside from the last price of $19.80.
Current Consensus is
The current consensus among 4 investment analysts is to buy stock in Covetrus. This rating has held steady since August 2020, when it changed from a Hold consensus rating.
Covetrus, Inc. engages in developing technologies and services for animal health industry. It also provides products, software, and services to help drive improved patient health, strong client relationships and successful financial outcomes for veterinary professionals. The firm geographically operates through the segments: North America, Europe and Asia Pacific (APAC) & Emerging Markets. The company was founded by Benjamin J. Shaw in 2014 and is headquartered in Portland, ME.